I agree that this site is using cookies. You can find further informations here.
X
Navinés-Ferrer, A. (Arnau)
37  results:
Search for persons X
?
1

Efficient correction of ABCA4 variants by CRISPR-Cas9 in hi..:

Siles, Laura ; Ruiz-Nogales, Sheila ; Navinés-Ferrer, Arnau..
Molecular Therapy - Nucleic Acids.  32 (2023)  - p. 64-79 , 2023
Link: https://doi.org/10.1016/..
 
?
2

SH3BP2 Silencing Increases miRNAs Targeting ETV1 and Microp..:

Proaño-Pérez, Elizabeth ; Serrano-Candelas, Eva ; Mancia, Cindy...
Cancers.  14 (2022)  24 - p. 6198 , 2022
Link: https://doi.org/10.3390/..
 
?
3

The microphthalmia-associated transcription factor is invol..:

Proaño-Pérez, Elizabeth ; Serrano-Candelas, Eva ; García-Valverde, Alfonso...
Cancer Gene Therapy.  30 (2022)  2 - p. 245-255 , 2022
Link: https://doi.org/10.1038/..
 
?
4

Impaired Bestrophin Channel Activity in an iPSC-RPE Model o..:

Navinés-Ferrer, Arnau ; Ruiz-Nogales, Sheila ; Navarro, Rafael.
International Journal of Molecular Sciences.  23 (2022)  13 - p. 7432 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Correction to: The microphthalmia-associated transcription ..:

Proaño-Pérez, Elizabeth ; Serrano-Candelas, Eva ; García-Valverde, Alfonso...
Cancer Gene Therapy.  30 (2022)  2 - p. 388-388 , 2022
Link: https://doi.org/10.1038/..
 
?
6

Mutation in KARS: A novel mechanism for severe anaphylaxis:

Ribó, Pau ; Guo, Yanru ; Aranda, Juan...
Journal of Allergy and Clinical Immunology.  147 (2021)  5 - p. 1855-1864.e9 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Author Correction: MRGPRX2-mediated mast cell response to d..:

Navinés-Ferrer, Arnau ; Serrano-Candelas, Eva ; Lafuente, Alberto...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
8

Myo1f, an Unconventional Long-Tailed Myosin, Is a New Partn..:

Navinés-Ferrer, Arnau ; Ainsua-Enrich, Erola ; Serrano-Candelas, Eva..
Frontiers in Immunology.  10 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
9

MRGPRX2-mediated mast cell response to drugs used inperiope..:

Navinés-Ferrer, Arnau ; Serrano-Candelas, Eva ; Lafuente, Alberto...
Scientific Reports.  8 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
10

IgE-Related Chronic Diseases and Anti-IgE-Based Treatments:

Navinés-Ferrer, Arnau ; Serrano-Candelas, Eva ; Molina-Molina, Gustavo-J.
Journal of Immunology Research.  2016 (2016)  - p. 1-12 , 2016
Link: https://doi.org/10.1155/..
 
?
11

Efficient correction of ABCA4 variants by CRISPR-Cas9 in hi..:

Laura Siles ; Sheila Ruiz-Nogales ; Arnau Navinés-Ferrer..
http://www.sciencedirect.com/science/article/pii/S2162253123000525.  , 2023
Link: https://doi.org/10.1016/..
 
?
12

Efficient correction of ABCA4 variants by CRISPR-Cas9 in hi..:

Siles, Laura ; Ruiz-Nogales, Sheila ; Navinés-Ferrer, Arnau..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034418/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

SH3BP2 Silencing Increases miRNAs Targeting ETV1 and Microp..:

Elizabeth Proaño-Pérez ; Eva Serrano-Candelas ; Cindy Mancia...
https://www.mdpi.com/2072-6694/14/24/6198.  , 2022
Link: https://doi.org/10.3390/..
 
?
14

Impaired Bestrophin Channel Activity in an iPSC-RPE Model o..:

Arnau Navinés-Ferrer ; Sheila Ruiz-Nogales ; Rafael Navarro.
Molecular Pathology, Diagnostics, and Therapeutics.  , 2022
Link: https://doi.org/10.3390/..
 
?
15

SH3BP2 Silencing Increases miRNAs Targeting ETV1 and Microp..:

Elizabeth Proaño-Pérez ; Eva Serrano-Candelas ; Cindy Mancia...
Molecular Cancer Biology.  , 2022
Link: https://doi.org/10.3390/..
 
1-15